110 related articles for article (PubMed ID: 37466585)
1. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
[TBL] [Abstract][Full Text] [Related]
2. Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
Zeitlinger L; Wilson M; Randall RL; Thorpe S;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):79-86. PubMed ID: 37466584
[TBL] [Abstract][Full Text] [Related]
3. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
[TBL] [Abstract][Full Text] [Related]
4. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
[TBL] [Abstract][Full Text] [Related]
5. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
Jackson KJ; Sullivan CD; Zimel MN; Wustrack RL;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):49-56. PubMed ID: 37466580
[TBL] [Abstract][Full Text] [Related]
6. Proximal Tibia Reconstruction After Bone Tumor Resection: Are Survivorship and Outcomes of Endoprosthetic Replacement and Osteoarticular Allograft Similar?
Albergo JI; Gaston CL; Aponte-Tinao LA; Ayerza MA; Muscolo DL; Farfalli GL; Jeys LM; Carter SR; Tillman RM; Abudu AT; Grimer RJ
Clin Orthop Relat Res; 2017 Mar; 475(3):676-682. PubMed ID: 27103142
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
; Ghert M; Schneider P; Guyatt G; Thabane L; Vélez R; O'Shea T; Randall RL; Turcotte R; Wilson D; Wunder JS; Baptista AM; Cheng EY; Doung YC; Ferguson PC; Giglio V; Hayden J; Heels-Ansdell D; Khan SA; Sampath Kumar V; McKay P; Miller B; van de Sande M; Zumárraga JP; Bhandari M
JAMA Oncol; 2022 Mar; 8(3):345-353. PubMed ID: 34989778
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review.
Thornley P; Vicente M; MacDonald A; Evaniew N; Ghert M; Velez R
Clin Orthop Relat Res; 2019 Apr; 477(4):894-902. PubMed ID: 30801278
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus.
Benevenia J; Kirchner R; Patterson F; Beebe K; Wirtz DC; Rivero S; Palma M; Friedrich MJ
Clin Orthop Relat Res; 2016 Feb; 474(2):539-48. PubMed ID: 26475032
[TBL] [Abstract][Full Text] [Related]
12. Central Adjudication Committee and Clinical Site Investigator Agreement on Outcomes in the PARITY Trial: A Secondary Analysis of the PARITY Trial Data.
Slawaska-Eng D; Giglio V; Gazendam AM; Schneider P; Bernthal N; Ghert M;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):73-78. PubMed ID: 37466583
[TBL] [Abstract][Full Text] [Related]
13. Does the Use of Negative Pressure Wound Therapy and Postoperative Drains Impact the Development of Surgical Site Infections?: A PARITY Trial Secondary Analysis.
LiBrizzi CL; Sabharwal S; Forsberg JA; Leddy L; Doung YC; Morris CD; Levin AS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):34-40. PubMed ID: 37466578
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for All-Cause Early Reoperation Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis from the PARITY Trial.
Kendal JK; Slawaska-Eng D; Gazendam A; Schneider P; Wessel LE; Ghert M; Bernthal NM;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):4-9. PubMed ID: 37466573
[TBL] [Abstract][Full Text] [Related]
15. Do Massive Allograft Reconstructions for Tumors of the Femur and Tibia Survive 10 or More Years after Implantation?
Aponte-Tinao LA; Ayerza MA; Albergo JI; Farfalli GL
Clin Orthop Relat Res; 2020 Mar; 478(3):517-524. PubMed ID: 32168064
[TBL] [Abstract][Full Text] [Related]
16. What Are the Risk Factors and Management Options for Infection After Reconstruction With Massive Bone Allografts?
Aponte-Tinao LA; Ayerza MA; Muscolo DL; Farfalli GL
Clin Orthop Relat Res; 2016 Mar; 474(3):669-73. PubMed ID: 25991435
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.
Gallagher M; Jones DJ; Bell-Syer SV
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005360. PubMed ID: 31557310
[TBL] [Abstract][Full Text] [Related]
18. Intracavity lavage and wound irrigation for prevention of surgical site infection.
Norman G; Atkinson RA; Smith TA; Rowlands C; Rithalia AD; Crosbie EJ; Dumville JC
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012234. PubMed ID: 29083473
[TBL] [Abstract][Full Text] [Related]
19. How Successful Is Antibiotic Treatment for Superficial Surgical Site Infections After Open Fracture? A Fluid Lavage of Open Wounds (FLOW) Cohort Secondary Analysis.
Prada C; Tanner SL; Marcano-Fernández FA; Bzovsky S; Schemitsch EH; Jeray K; Petrisor B; Bhandari M; Sprague S;
Clin Orthop Relat Res; 2020 Dec; 478(12):2846-2855. PubMed ID: 32412929
[TBL] [Abstract][Full Text] [Related]
20. Topical antibiotics for preventing surgical site infection in wounds healing by primary intention.
Heal CF; Banks JL; Lepper PD; Kontopantelis E; van Driel ML
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011426. PubMed ID: 27819748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]